Paper - WANFANG MED ONLINE

You Position: Home > Paper

中国继发性高血压临床筛查多学科专家共识(2023)

( views:523, downloads:726 )

Author:: No author available

Journal Title:: Prevention and Treatment of Cardio-Cerebral-Vascular Disease

Issue:: 1

DOI:: 10.3969/j.issn.1009-816x.2023.01.001

Key Word:: No keyword available

Abstract：近三十年来,随着人民物质生活水平的不断提高,以及全社会人口老龄化进程的日益加快,心血管疾病发病率和死亡率呈明显上升趋势,已成为影响我国人民健康的头号危险因素.我国每年约有350万人死于心血管疾病,提高心血管疾病的防治水平已被列入"健康中国2030"规划纲要.

Reference

[1]中华医学会心血管病学分会精准心血管病学学组,中国医疗保健国际交流促进会精准心血管病分会,中华心血管病杂志编辑委员会.单基因遗传性心血管疾病基因诊断指南[J].2019,(3).
[2]中国中医药研究促进会中西医结合心血管病预防与康复专业委员会高血压专家委员会,北京高血压防治协会,中国高血压联盟,等.特殊类型高血压临床诊治要点专家建议[J].2020,(10).
[3]钱婧雨,刘向祎.醛固酮检测方法及临床应用进展[J].2019,(12).
[4]蔡广研,陈香美.进一步加强肾性高血压管理改善疾病预后[J].2017,(20).
[5]邹玉宝(综述),宋雷,蒋雄京(审校).大动脉炎诊断标准研究进展[J].2017,(1).
[6]大动脉炎相关高血压诊治多学科共识中国专家组.中国大动脉炎相关高血压诊治多学科专家共识[J].2021,(2).
[7]安仕敏,王文尧,唐熠达.促甲状腺素水平升高与动脉硬化及高血压独立相关[J].2017,(z1).
[8]中国医疗保健国际交流促进会血管疾病高血压分会专家共识起草组.肾动脉狭窄的诊断和处理中国专家共识[J].2017,(9).
[9]中国医师协会肾脏内科医师分会,中国中西医结合学会肾脏疾病专业委员会.中国肾性高血压管理指南2016（简版）[J].2017,(20).
[10]颜京,张婷婷,赵葵.核医学分子影像探针应用于神经内分泌肿瘤的研究进展[J].2021,(1).
[11]国家卫生健康委高血压诊疗研究重点实验室学术委员会.高血压患者中原发性醛固酮增多症检出、诊断和治疗的指导意见[J].2021,(6).
[12]Raff, Hershel,Auchus, Richard J.,Findling, James W.,etc.Urine Free Cortisol in the Diagnosis of Cushing's Syndrome: Is It Worth Doing and, If So, How?[J].2015,100(2).
[13]Hartmut P H,Neumann,Uliana,Tsoy,Irina,Bancos,etc.Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.[J].2019,2(8).
[14]Chung F,Yegneswaran B,Liao P,etc.STOP questionnaire: a tool to screen patients for obstructive sleep apnea.[J].2008,108(5).
[15]I, Klein,K, Ojamaa.Thyroid hormone and the cardiovascular system.[J].2001,344(7).
[16]Segawa Hiroyoshi,Higashi Akane,Masuda Izuru,etc.Urinary sodium/potassium ratio as a screening tool for hyperaldosteronism in men with hypertension[J].2021,44(9).
[17]Carlos E, Martinelli,Julia M, Keogh,Jerry R, Greenfield,etc.Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.[J].2011,96(1).
[18]A, Hata,M, Noda,R, Moriwaki,etc.Angiographic findings of Takayasu arteritis: new classification.[J].1996,54 Suppl.
[19]Rossi,G.P.,Auchus,R.J.,Brown,M.,etc.An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[J].2014,63(1).
[20]Georgios Daniil,Fabio L Fernandes-Rosa,Jean Chemin,etc.CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism[J].2016.
[21]Rollin, Guilherme A. F.,Costenaro, Fabiola,Gerchman, Fernando,etc.Evaluation of the DDAVP test in the diagnosis of Cushing's Disease[J].2015,82(6).
[22]Christina Pamporaki.Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas[J].2017,102(4).
[23]Jenn Rachelle U. Santos,Alessra Brofferio,Bruna Viana,etc.Catecholamine-lnduced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?[J].2019,51(7).
[24]Tassone, Francesco.Pheochromocytoma and Paraganglioma[J].2019,381(19).
[25]Young, W. F..Diagnosis and treatment of primary aldosteronism: practical clinical perspectives[J].2019,285(2).
[26]Kayser, Sabine C.,Dekkers, Tanja,Groenewoud, Hans J.,etc.Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis[J].2016,101(7).
[27]Feelders, Richard A.,Nieman, Lynnette K.,Lacroix, Andre,etc.Cushing's syndrome[J].2015,386(9996).
[28].The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas��A Meta-Analysis and Systematic Review of the Literature.[J].2019,11(2).
[29]赵连友,孙英贤,李玉明,等.高血压合并动脉粥样硬化防治中国专家共识[J].2020,(2).
[30]Jahandideh Dariush,Swearingen Brooke,Nachtigall Lisa B.,etc.Characterization of cyclic Cushing's disease using late night salivary cortisol testing[J].2018,89(3).
[31]Taïeb David,Hicks Rodney J.,Hindié Elif,etc.European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma[J].2019,46(10).
[32]Garcia-Carbonero R.,Matute Teresa F.,Mercader-Cidoncha E.,etc.Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas[J].2021,23(10).
[33]E H, Oldfield,J L, Doppman,L K, Nieman,etc.Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.[J].1991,325(13).
[34]Deipolyi, Amy R.,Alexander, Bailin,Rho, Jun,etc.Bilateral inferior petrosal sinus sampling using desmopressin or corticotropic-releasing hormone: a single-center experience[J].2015,7(9).
[35]中华医学会内分泌学分会.原发性醛固酮增多症诊断治疗的专家共识（2020版）[J].2020,36(9).
[36].Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome[J].2020,105(6).
[37]Mol, Ben W. J.,Hofmeyr, G. Justus,Magee, Laura A.,etc.Pre-eclampsia[J].2016,387(10022).
[38]Raff, Hershel,Cohen, Eric P.,Findling, James W..A commentary on Diagnosing Cushing's disease in the context of renal failure[J].2019,181(4).
[39]Sundin, Anders,Arnold, Rudolf,Baudin, Eric,etc.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging[J].2017,105(3).
[40]Brown, Mark A.,Magee, Laura A.,Kenny, Louise C.,etc.Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice[J].2018,72(1).
[41]Castinetti,F.,Qi,X.-P.,Walz,M.K.,etc.Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: An international retrospective population-based study[J].2014,15(6).
[42]Letizia C,Zinnamosca L,Saponara M,etc.Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism.[J].2010,11(3).
[43]原著Joseph L. Izzo, Jr., MD, Domenic A. Sica, MD, Henry R. Black, MD 主译王文, 高玖鸣, 马丽媛.高血压手册[M].1900.
[44]Funder, John W.,Carey, Robert M.,Mantero, Franco,etc.The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline[J].2016,101(5).
[45]Rossi, Gian Paolo,Bisogni, Valeria,Rossitto, Giacomo,etc.Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension[J].2020,27(6).
[46]Luca Manetti,Giuseppe Rossi,Lucia Grasso,etc.Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol[J].2013,168(3).
[47]Choi, Jungmin,Xu, Shengxin,Rump, Lars C.,etc.CLCN2 chloride channel mutations in familial hyperaldosteronism type II[J].2018,50(3).
[48]Bilo, Grzegorz,Villafuerte, Francisco C.,Faini, Andrea,etc.Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude The High Altitude Cardiovascular Research-Andes Study[J].2015,65(6).
[49]Anna Angelousi,Melpomeni Peppa,Alexandra Chrisoulidou,etc.Malignant Pheochromocytomas\/Paragangliomas and Ectopic Hormonal Secretion: A Case Series and Review of the Literature[J].2019,11(5).
[50]Simsek,D.H.,Kuyumcu,S.,Turkmen,C.,etc.Can complementary 68Ga-dotatate and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?[J].2014,55(11).